The effects of atorvastatin therapy on endothelial function in patients with coronary artery disease

Cardiovascular Ultrasound

Volumn 5, Issue , 2007, Pages

  Yildiz, Ahmet ^a   Cakar, M Akif ^b   Baskurt, Murat ^b   Okcun, Baris ^b   Guzelsoy, Deniz ^b   Coskun, Ugur ^b  

^a Gazi Hospital   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; C REACTIVE PROTEIN; HEPTANOIC ACID DERIVATIVE; HYPOCHOLESTEROLEMIC AGENT; PYRROLE DERIVATIVE;

ADULT; ARTICLE; BRACHIAL ARTERY; CELL FUNCTION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DRUG DOSE INCREASE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; GENERAL AND MISCELLANEOUS PROCEDURES AND TECHNIQUES; HUMAN; MALE; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; VASODILATATION; ANGIOCARDIOGRAPHY; BLOOD; ECHOGRAPHY; METABOLISM; MIDDLE AGED; TREATMENT OUTCOME; VASCULAR ENDOTHELIUM;

ANTICHOLESTEREMIC AGENTS; C-REACTIVE PROTEIN; CHOLESTEROL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HEPTANOIC ACIDS; HUMANS; MALE; MIDDLE AGED; PYRROLES; TREATMENT OUTCOME;

EID: 39149097821     PISSN: None     EISSN: 14767120     Source Type: Journal    
DOI: 10.1186/1476-7120-5-51     Document Type: Article

References (26)

1. The value of lowering cholesterol after myocardial infarction. JE Rossouw B Lewis BM Rifkind, N Engl J Med 323 16 1112 9 1990 Oct 18 2215579
2. Hormone replacement therapy and endothelial function: the exception that proves the rule? JA Vita JF Keaney Jr, Arterioscler Thromb Vasc Biol 2001 21 1867 1869 11742856
3. Influence of pravastatin and plasma lipids on clinical events in the West of Scotland Coronary Prevention study (WOSCOPS). West of Scotland Coronary Prevention study group, Circulation 97 15 1440 1445 1998 Apr 21 9576423
4. Plasma cholesterol concentration and mortality. The Whitehall Study. GD Smith MJ Shipley MG Marmot G Rose, J Am Med Assoc 267 1 70 6 1992 Jan 1 10.1001/jama.267.1.70
5. Close relation of endothelial function in the human coronary and peripheral circulations. TJ Anderson A Uehata MD Gerhard IT Meredith S Knab D Delagrange EH Lieberman P Ganz MA Creager AC Yeung AP Selwyn, J Am Coll Cardiol 26 1235 1241 1995 Nov 1 7594037 10.1016/0735-1097(95)00327-4
6. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. MC Corretti TJ Anderson EJ Benjamin D Celermajer F Charbonneau MA Creager J Deanfield H Drexler M Gerhard-Herman D Herrington P Vallance J Vita R Vogel International Brachial Artery Reactivity Task Force, J Am Coll Cardiol 39 2 257 65 2002 Jan 16 11788217 10.1016/S0735-1097(01)01746-6
7. Flow-induced vasodilation of the human brachial artery is impaired in patients <40 years of age with coronary artery disease. EH Lieberman MD Gerhard A Uehata AP Selwyn P Ganz AC Yeung MA Creager, Am J Cardiol 78 11 1210 4 1996 Dec 1 8960576 10.1016/S0002-9149(96)00597-8
8. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. DS Celermajer KE Sorensen VM Gooch DJ Spiegelhalter OI Miller ID Sullivan JK Lloyd JE Deanfield, Lancet 1992 340 1111 1115 1359209 10.1016/0140-6736(92)93147-F
9. Comparative study of the effect of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study]. E Eleuteri, Ital Heart J Suppl 2000 1 6 830 831 11204017
10. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. GB Mancini GC Henry C Macaya BJ O'Neill AL Pucillo RG Carere TJ Wargovich H Mudra TF Lüscher MI Klibaner HE Haber AC Uprichard CJ Pepine B Pitt, Circulation 94 3 258 265 1996 Aug 1 8759064
11. Aspirin improves endothelial dysfunction in atherosclerosis. S Husain NP Andrews D Mulcahy JA Panza AA Quyyumi, Circulation 97 8 716 720 9498533
12. Lipid lowering and plaque regression. New insights into prevention of plaque disruption and clinical events in coronary disease. BG Brown XQ Zhao DE Sacco JJ Albers, Circulation 1993 87 6 1781 1791 8504494
13. Endothelial control of vascular tone in large and small coronary arteries. TF Lücher V Richard M Tschudi ZH Yang C Boulanger, J Am Coll Cardiol 15 3 519 27 1990 Mar 1 2406318
14. Sex differences in endothelial function in normal and hypercholesterolaemic subjects. PJ Chowienczyk GF Watts JR Cockcroft SE Brett JM Ritter, Lancet 344 305 306 1994 Jul 30 7914265 10.1016/S0140-6736(94)91342-0
15. Randomized FARVATER study. Effect of atorvastatin on endothelial function, distensibility and stiffness of vascular wall. AV Susekov TA Rozhkova MI Tripoten' OA Pogorelova BD Kulev TV Balakhonova MIu Zubareva VP Masenko AN Rogozova VV Kukharchuk, Kardiologiia 2007 47 2 25 30 17495819
16. Influence of statin use on endothelial function: from bench to clinics. J Martinez-González L Badimon, Curr Pharm Des 2007 13 17 1771 86 17584107 10.2174/138161207780831220
17. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. AM Zeiher H Drexler H Wollschläger H Just, Circulation 1991 83 2 391 401 1991363
18. Endothelium-mediated coronary blood flow modulation in humans. Effects of age, atherosclerosis, hypercholesterolemia, and hypertension. AM Zeiher H Drexler B Saurbier H Just, J Clin Invest 1993 92 2 652 662 8349804
19. Reduction of transient myocardial ischemia with pravastatin in addition to the conventional treatment in patients with angina pectoris. AJ van Boven JW Jukema AH Zwinderman HJ Crijns KI Lie AV Bruschke, REGRESS Study Group Circulation 94 7 1503 1505 1996 Oct 1
20. Improvement of myocardial ischemia by lipid lowering drugs. D Tzivoni J Klein, Eur Heart J 1998 19 2 230 234 9519315 10.1053/euhj.1997.0724
21. Direct vascular effects of HMG-CoA reductase inhibitors. S Bellosta F Bernini N Ferri P Quarato M Canavesi L Arnaboldi R Fumagalli R Paoletti A Corsini, Atherosclerosis 1998 137 Suppl S101 9 9694549 10.1016/S0021-9150(97) 00319-5
22. Improvement of myocardial perfusion by short-term fluvastatin therapy in coronary artery disease. HW Eichstädt H Eskötter I Hoffman HW Amthauer G Weidinger, Am J Cardiol 76 2 122A 125A 1995 Jul 13 7604786 10.1016/S0002-9149(05)80033-5
23. Simvastatin, an HMG-coenzyme A reductase inhibitör, improves endothelial function within 1 month. G O'Driscoll D Green RR Taylor, Circulation 95 5 1126 1131 1997 Mar 4 9054840
24. Cholesterol reduction rapidly improves endothelial function after acute coronary syndromes - The RECIFE (reduction of cholesterol in ischemia and function of the endothelium) trial. J Dupuis JC Tardif P Cemacek P Theroux, Circulation 1999 99 3227 3233 10385495
25. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. TJ Anderson IT Meredith AC Yeung B Frei AP Selwyn P Ganz, N Engl J Med 332 8 488 93 1995 Feb 23 7830729 10.1056/NEJM199502233320802
26. Rapid effects on vascular function after initiation and withdrawal of atorvastatin in healthy, normocholesterolemic men. U Laufs S Wassmann S Hilgers N Ribaudo M Böhm G Nickenig, Am J Cardiol 88 11 1306 7 2001 Dec 1 11728362 10.1016/S0002-9149(01)02095-1